Fresenius SE & Co. KGaA (FSNUY)
Healthcare · PNK
Price as at 1 Oct 2026, 10:11 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Fresenius SE & Co. KGaA trades at $12.66, which is 106% below the $26.07 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.
Our moat model scores it 38 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 16.0 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
FSNUY dividend history
Dividends per share by year
| Year | Total per share | Payments |
|---|---|---|
| 2026 (year to date) | $0.307 | 1 |
| 2025 | $0.283 | 1 |
| 2023 | $0.247 | 1 |
| 2022 | $0.242 | 1 |
| 2021 | $0.267 | 1 |
| 2020 | $0.238 | 1 |
| 2019 | $0.225 | 1 |
| 2018 | $0.230 | 1 |
| 2017 | $0.164 | 1 |
| 2016 | $0.155 | 1 |
| 2015 | $0.123 | 1 |
Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.
FSNUY earnings and analyst estimates
Recommendation mix, 3 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
FSNUY passes 3 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Politician trades in FSNUY
Trades in FSNUY disclosed by members of Congress and executive-branch officials, latest first:
- Alan Armstrong · SenateBuy · $1,001 - $15,000 · traded 30 Mar 2026 · disclosed 21 Jul 2026
- Greg Gianforte · HouseSell · $1,001 - $15,000 · traded 21 Dec 2018 · disclosed 23 Jan 2019
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
FSNUY peers
The largest companies in the same industry (Medical Care Facilities), then in the same sector.
- THC Tenet Healthcare Corporation
- FMS Fresenius Medical Care AG
- ENSG The Ensign Group, Inc.
- UHS Universal Health Services, Inc.
- RHC.AX Ramsay Health Care Limited
- CHE Chemed Corporation
- CON Concentra Group Holdings Parent, Inc.
- OPCH Option Care Health, Inc.
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is Fresenius SE & Co. KGaA (FSNUY) undervalued?
Against our fair value estimate of $26.07, FSNUY at $12.66 is 106% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
What is FSNUY's P/E ratio?
FSNUY trades at 16.0 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
Does Fresenius SE & Co. KGaA (FSNUY) pay a dividend?
Yes. Fresenius SE & Co. KGaA yields 2.50% at the current share price. It has paid $0.307 per share over the trailing twelve months. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.
Where does SteadyShares get its FSNUY data?
Fundamentals for FSNUY come from company filings and exchange data, as listed on PNK; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 10:11 UTC and is delayed. Our data quality score for this company is 100/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for FSNUY, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.